Insulet (PODD) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Wedbush Raises Price Target on Insulet (PODD) Following 3Q
November 6, 2015 8:45 AM ESTWedbush reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $44.00 (from $40.00), following the company's 3Q earnings report. The new managements team is successfully capturing a healthy number of new patients (almost 25% yr/yr) through improved marketing... More
